Long-term clinical and neurophysiologica
β
Sawanthana Ponsford; Hugh Willison; Jean Veitch; Richard Morris; P.K. Thomas
π
Article
π
2000
π
John Wiley and Sons
π
English
β 216 KB
π 2 views
The incidence of hematological malignancy in patients with monoclonal gammopathy of undetermined significance (MGUS) has been assessed as 17% to 25%. To ascertain whether this is true of neuropathy associated with MGUS, a long-term (5-42 years) retrospective clinical and neurophysiological follow-up